Multi-sponsored session: From crisis to opportunity: Global leadership in liver cancer prevention

Liver cancer is the third leading cause of cancer death worldwide, a devastating fact made more urgent by its largely preventable nature. Without immediate action, the global burden will rise sharply, yet proven interventions—hepatitis vaccination and treatment, and early detection strategies—offer a powerful opportunity to change the future.

This session will spotlight liver cancer as both a global health crisis and a social equity issue, disproportionately affecting vulnerable communities. It will explore the biggest gaps in prevention, early diagnosis, and treatment, and examine how these can be bridged through political commitment, smart resource allocation, and integration into existing health systems.

Speakers will highlight successes and lessons learned from diverse contexts, demonstrating how real-world progress can be achieved even in challenging environments. Discussions will address cost–benefit evidence, innovations in diagnostics and therapeutics, and the levers that make prevention strategies work.

- Lightning Talk 1 – Beating liver cancer through hepatitis elimination – Cary James, CEO, World Hepatitis Alliance

- Lightning Talk 2 – Successes and challenges of combatting HCC in Hong Kong – Professor Anne Lee, Hong Kong Ambassador, World Cancer Research Fund; Vice Chairman, Hong Kong Anti-Cancer Society

- Lightning Talk 3 – Overview of the Egyptian HCC surveillance and management program – Dr Mohamed AbdAllah, Consultant of Hepatogastroenterology, National Research Center, Egypt; Executive Director, Egyptian Program for HCC Surveillance and Management, Ministry of Health and Population

- Lightning Talk 4 – Taiwan: Success in Early Detection and Treatment – How national HCC surveillance programs led to decreasing liver cancer mortality – Dr Ching-Fen Shen, Director General, Health Promotion Administration, Taiwan

- Lightning Talk 5 – Liver Cancer Prevention in Mongolia (tentative title) – Dr Tsetsegsaikhan Batmunkh, CEO, National Cancer Council of Mongolia

- Lightning Talk 6 – Industry perspective – Dr Bob Li, Head of Medical Affairs, Oncology, AstraZeneca

This session is supported by AstraZeneca

More sponsors might take part to this session